Clinical Guest Contributors

1. Two Parallel Trials, A Potential New Option For Protection From COVID-19 11/10/2026

   Invivyd’s Michael Mina, MD, Ph.D., discusses LIBERTY and DECLARATION, exploring how monoclonal antibodies could expand COVID-19 protection alongside vaccines.

2. Firsthand Findings: How Incannex Is Designing Trials That Support Regulatory Approval 11/9/2026

   Incannex CEO Joel Latham explains how thoughtful trial design and dose optimization can turn promising data into an approval-ready strategy.

3. The 2026 Pharma R&D AI Sourcing Map: Partnerships, Concentration, Inflection 11/9/2026

   A Beroe analysis of 2026 pharma AI deals shows discovery still dominates, suppliers are consolidating, and clinical development is the next AI sourcing frontier.

4. Novel Science, Familiar Regulatory Pathways: Inside Tonix's Clinical Development Strategy 11/6/2026

   Tonix CEO Seth Lederman, MD, explains how the company pairs novel science with proven regulatory paths across fibromyalgia, depression, and Lyme disease.

5. Lupus Researchers Now Have A Three-Pillar RWD Platform To Support Discovery And Development 11/6/2026

   Lupus Nexus unites a registry, biorepository, and data exchange to give researchers longitudinal real-world data without building the infrastructure from scratch.

6. As U.S. Trial Share Slips, A Coalition Maps A Path To Broader Patient Access 11/6/2026

   Milken Institute's Kristin Schneeman explains how a new action plan could broaden patient access in the U.S. — and what sponsors and policymakers can do now.

7. A Window Into Aging: Why Skin Is the First Test For RLS-1496 11/5/2026

   Rubedo’s Marco Quarta explains how patient selection, controls, biopsies, and biomarkers shaped early RLS-1496 trial protocols.

8. Brazil's Regulatory Transformation: Building And Supporting Sites Beyond The AMCs 11/4/2026

   Our expert chat about Brazil’s clinical research transformation concludes with SBOC President-elect Fabio Franke, who explores building sustainable trial capacity beyond the country’s major AMCs.

9. Brazil's Regulatory Transformation: Expanding Clinical Trial Participation 11/3/2026

   A discussion of Brazil’s clinical research transformation continues as this Q&A series turns to Maiko L. Tonini, Ph.D., of Brazil’s Ministry of Health, to explore expanding clinical trial participation.

10. Brazil's Regulatory Transformation: A New Era For Clinical Development 11/2/2026

    Brazil’s clinical research transformation takes center stage as this new Q&A series opens with Interfarma CEO and former ANVISA director Renato Porto.